Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference

Core Insights - Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for rare and difficult-to-treat diseases [3] - The company will participate in the Jefferies Global Healthcare Conference on November 17, 2025, with a presentation scheduled at 2:00 pm GMT [1][2] - Catalyst has been recognized for its growth and success, being listed as one of America's Most Successful Mid-Cap Companies by Forbes in 2025 and one of North America's Fastest-Growing Companies by Deloitte in 2024 [3] Company Overview - Catalyst Pharmaceuticals is headquartered in Coral Gables, Florida, and is committed to improving the lives of patients with rare diseases [3] - The company emphasizes in-licensing, commercialization, and development of innovative therapies, ensuring patient accessibility through comprehensive support services [3] - Catalyst maintains a strong presence in the U.S. market while exploring opportunities for global expansion [3]